I

Intuitive Surgical

Builds robots for minimally invasive surgery

Full-Stack Software Engineer

Full-TimePosted on 10/20/2026
$47 - $75
Junior
Bachelor's
Sunnyvale, CA, USA
HybridHybrid work in Sunnyvale, California; preference given to candidates not residing or planning to reside in 14 listed states.
Software EngineeringFull-Stack Engineering

About the job

Requirements
  • The role targets junior or early-career candidates with 1–2 years of professional experience.
  • A bachelor's degree in Computer Science, Software Engineering, Information Systems, or a related technical field is required; equivalent practical experience may be accepted in lieu of the degree.
  • Relevant coursework or self-study in Web Development, Cloud Computing, Databases, Software Engineering, or AI/ML is relevant.
  • 1–2 years of hands-on Python experience, professional or project-based, is required.
  • Experience contributing to or shipping React and TypeScript user interface features in a real or production-like environment is required.
  • A solid understanding of REST API design and client-server architecture is required.
  • Working experience with at least one major cloud provider, demonstrated by deploying or managing cloud resources in a real project, is required.
  • Hands-on experience with Docker and containerized deployments is required.
  • Active experience working within CI/CD pipelines is required.
  • Experience with LLM APIs in at least one professional, personal, or academic project is required.
  • Working knowledge of OAuth 2.0 or OIDC authentication flows, including implementation or debugging in a real application, is required.
  • Awareness of secure coding practices and data privacy principles is required.
  • Ability to work with non-technical stakeholders to clarify requirements and translate feedback into actionable tasks is required.
  • Ability to take end-to-end ownership of features from ticket through production is required.
  • Ability to iterate amid ambiguity, make reasonable decisions, and know when to escalate is required.
  • The candidate should value code quality, testing, and documentation.
  • The candidate should be eager to grow toward senior-level independence and proactively seek and apply feedback.
Responsibilities
  • Design, build, and maintain the frontend and backend of a new internal AI-powered platform, owning features from development through production deployment.
  • Build and maintain integrations between the platform and cloud services, AI APIs, and internal data sources.
  • Write clean, tested, and well-documented code across the full stack, including a Python backend and React/TypeScript frontend.
  • Contribute to architectural discussions with guidance from senior engineers, considering system design beyond individual features.
  • Integrate generative AI and large language model capabilities into the platform to help business teams find information, answer questions, and automate repetitive workflows.
  • Begin applying agentic and tool-calling patterns with growing independence and support from senior engineers.
  • Partner with business teams to understand workflows and translate them into working software features, with guidance on scoping and prioritization.
  • Participate in design reviews, sprint planning, and retrospectives.
  • Communicate progress, blockers, and tradeoffs to technical and non-technical stakeholders.
  • Implement secure authentication and access control using OAuth 2.0 or OIDC for sensitive business data.
  • Follow and contribute to data governance practices to ensure the platform handles information responsibly.
  • Contribute to and follow team engineering practices, including unit testing, integration testing, code reviews, and documentation.
  • Work within CI/CD pipelines to build, test, and deploy features to production.
  • Use observability and monitoring tools to diagnose issues and understand production platform health.
  • Gather and act on real user feedback to iterate on features over time.
  • Ship incrementally while maintaining production quality and balancing speed with reliability.
Desired Qualifications
  • Exposure to FastAPI or a comparable asynchronous framework is a plus.
  • Azure is preferred among major cloud providers; AWS or GCP are also considered.
  • Growing familiarity with agentic patterns and tool-calling is a strong differentiator.

About the company

Intuitive Surgical makes da Vinci robots that let surgeons operate through a few small incisions, and Ion, a robot that reaches deep into the lungs to take tissue samples. In 2000, da Vinci became the first robotic system cleared by the FDA for general laparoscopic surgery, meaning keyhole operations in the abdomen. A surgeon sits at a nearby console and steers robotic arms holding a 3D camera and wristed instruments, which turn hand movements into smaller, steadier motions. Hospitals buy or lease the robots, then keep paying for the instruments used in each operation and for service. Intuitive was founded in 1995 to commercialize robotic surgery research from SRI International and is based in Sunnyvale, California.

Company Size

10,001+

Company Stage

IPO

Headquarters

Sunnyvale, California

Founded

1995

Get referred to Intuitive Surgical

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Demand keeps compounding: da Vinci procedures grew 15% and revenue 19%, to $2.89 billion, in the June 2026 quarter.
  • Room to grow: Intuitive listed 748 open roles in October 2026, including 191 in engineering and 312 in Sunnyvale.
  • Repeat sales steady the business: instruments and service made 76% of revenue in the June 2026 quarter.

What critics are saying

  • Stock grants have shrunk: shares fell 27% from January to October 2026, versus 9% for rival Medtronic.
  • Device giants are moving in: the FDA cleared rival robots from Medtronic in December 2025 and J&J in July 2026.
  • Instrument sales face a court fight: in August 2026, an appeals court revived a repair firm's monopoly suit against Intuitive.

What makes Intuitive Surgical unique

  • Hospitals rent more than they buy: 254 of 468 da Vinci systems placed in the June 2026 quarter were leases.
  • It runs without borrowing: Intuitive had no debt and $8.6 billion in cash and investments in June 2026.
  • Its CEO is a 30-year insider: Dave Rosa, CEO since July 2025, joined as employee number nine in 1996.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Hybrid Work Options

Growth & Insights and Company News

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Oct 1st, 2026
Intuitive Surgical down 30% in 2026, but Wall Street analysts stay bullish

Intuitive Surgical has lost nearly 30% year-to-date in 2026, making it one of healthcare's biggest losers. The stock fell over 40% by late July. Despite this decline, Wall Street remains bullish—24 of 32 analysts surveyed by S&P Global in September rated it a "buy" or "strong buy." The medical device maker faces several challenges. Growth is slowing whilst the stock trades at a forward price-to-earnings multiple over 33. Competition in China remains difficult, and the company now battles healthcare giants Johnson & Johnson, Medtronic, and Stryker in robotic surgical systems. The expiration of Affordable Care Act subsidies and rising GLP-1 drug usage have also impacted procedure volumes. However, the company's Asian revenue still jumped 20% year-over-year in Q2, suggesting these headwinds aren't insurmountable.

Yahoo Finance
Sep 17th, 2026
Intuitive Surgical, IonQ, and Accenture hold billions in net cash for growth

Investors seeking financial stability often look to companies with more cash than debt, as these businesses have greater flexibility for growth investments, buybacks, and dividends. Intuitive Surgical holds $5.22 billion in net cash. The robotic surgery pioneer achieved 20.7% annual revenue growth over the past two years, whilst its earnings per share increased 17.4% annually over five years. IonQ maintains $2.06 billion in net cash, representing 14.1% of its market capitalisation. The quantum computing company posted 181% annual revenue growth over two years and expects 163% growth next year. Accenture has $1.78 billion in net cash. The professional services firm employs approximately 774,000 people across more than 120 countries. Companies with strong balance sheets can navigate uncertain markets whilst pursuing expansion opportunities without the burden of significant debt obligations.

Yahoo Finance
Aug 23rd, 2026
Thermo Fisher vs Intuitive Surgical: which premium healthcare stock justifies valuation?

Thermo Fisher and Intuitive Surgical both delivered strong recent quarters, but their premium valuations rest on different foundations. Thermo Fisher's case depends on recovery in life sciences spending after the pandemic slowdown. The company's Life Sciences Solutions segment saw reported revenue climb 13% year-over-year, with organic revenue up 3%. The Analytical Instruments business returned to growth after nearly two years of weak demand, suggesting laboratory spending is normalising. Intuitive Surgical maintains its premium through business model strength. The company's non-GAAP gross profit margin reached 70.0%, whilst its non-GAAP operating margin expanded 330 basis points year-over-year to 42.1%. Recurring revenue streams constitute roughly 85% of total sales. Intuitive placed 468 da Vinci surgical units in fiscal Q2, marking 18% year-over-year growth, indicating continued hospital investment in robotic surgery platforms.

Yahoo Finance
Aug 19th, 2026
Abbott beats Q2 estimates with 13% sales growth as diagnostics surge 42%, while Intuitive Surgical posts 19% revenue rise

Abbott Laboratories reported strong fiscal Q2 2026 results, with sales rising 13% on a reported basis and 4.8% on a comparable basis, beating estimates and prompting the company to raise its annual profit forecast. The diagnostics segment was particularly strong, growing 42% to $3.09 billion, driven by its cancer diagnostics business following the Exact Sciences acquisition. Intuitive Surgical also exceeded expectations in Q2 2026, with revenue growing 19% to $2.89 billion and adjusted EPS of $2.80, beating forecasts by $0.30. The company placed 468 da Vinci units during the quarter, an 18% year-over-year increase, whilst maintaining a non-GAAP gross margin of 70.0%. The companies present contrasting investment cases: Abbott offers diversified healthcare portfolio resilience, whilst Intuitive Surgical relies on its robotic surgery ecosystem with recurring revenue comprising approximately 85% of total sales.

PR Newswire
Aug 17th, 2026
Intuitive leases 316,000-sq-ft facility in Penang to manufacture surgical instruments, create 1,200 jobs by 2032

Intuitive, the global leader in minimally invasive care and pioneer of robotic-assisted surgery, has signed a lease agreement with Penang Development Corporation for a new manufacturing facility in Malaysia. The 316,000-square-foot site in Bandar Cassia Technology Park will produce surgical instruments and electromechanical devices for Intuitive's da Vinci surgical system. The facility is expected to begin operations in 2028 and create 1,200 highly skilled jobs by 2032. The investment reflects Intuitive's commitment to Asia Pacific, where its da Vinci systems have treated more than 2.5 million patients across 13 markets over two decades. The expansion aims to support growing demand for robotic-assisted surgery across the region and strengthen Penang's position as a MedTech manufacturing hub in Southeast Asia.